Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
OtherClinical Investigations (Human)

Radiation dosimetry of Tc99m-PSMA I&S: a single-center prospective study

Szabolcs Urbán, Catherine Meyer, Magnus Dahlbom, István Farkas, Gábor Sipka, Zsuzsanna Besenyi, Johannes Czernin, Jeremie Calais and László Pávics
Journal of Nuclear Medicine December 2020, jnumed.120.253476; DOI: https://doi.org/10.2967/jnumed.120.253476
Szabolcs Urbán
1 University of Szeged, Hungary;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Szabolcs Urbán
Catherine Meyer
2 University of California Los Angeles;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Magnus Dahlbom
3 UCLA School of Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
István Farkas
1 University of Szeged, Hungary;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gábor Sipka
1 University of Szeged, Hungary;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zsuzsanna Besenyi
1 University of Szeged, Hungary;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johannes Czernin
3 UCLA School of Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeremie Calais
4 UCLA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jeremie Calais
László Pávics
1 University of Szeged, Hungary;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

jnumed.120.253476
DOI 
https://doi.org/10.2967/jnumed.120.253476
PubMed 
33277398

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online December 4, 2020.

Article Versions

  • You are currently viewing a previous version of this article (December 4, 2020 - 12:52).
  • View the most recent version of this article
Copyright & Usage 
Copyright © 2020 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Author Information

  1. Szabolcs Urbán1,
  2. Catherine Meyer2,
  3. Magnus Dahlbom3,
  4. István Farkas1,
  5. Gábor Sipka1,
  6. Zsuzsanna Besenyi1,
  7. Johannes Czernin3,
  8. Jeremie Calais4 and
  9. László Pávics1
  1. 1 University of Szeged, Hungary;
  2. 2 University of California Los Angeles;
  3. 3 UCLA School of Medicine;
  4. 4 UCLA
  1. For correspondence or reprints contact: Szabolcs Urbán, University of Szeged, Korányi fasor 6., Szeged, Csongrád-Csanád 6720, Hungary. E-mail: urban.szabolcs@med.u-szeged.hu

Statistics from Altmetric.com

Cited By...

  • 10 Citations
  • 12 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Molecular Imaging in Primary Staging of Prostate Cancer Patients: Current Aspects and Future Trends
    Reyhaneh Manafi-Farid, Shaghayegh Ranjbar, Zahra Jamshidi Araghi, Julia Pilz, Gregor Schweighofer-Zwink, Christian Pirich, Mohsen Beheshti
    Cancers 2021 13 21
  • Radiolabeled PSMA Inhibitors
    Oliver C. Neels, Klaus Kopka, Christos Liolios, Ali Afshar-Oromieh
    Cancers 2021 13 24
  • Incorporating PSMA-Targeting Theranostics Into Personalized Prostate Cancer Treatment: a Multidisciplinary Perspective
    Thomas S. C. Ng, Xin Gao, Keyan Salari, Dimitar V. Zlatev, Pedram Heidari, Sophia C. Kamran
    Frontiers in Oncology 2021 11
  • Feasibility of fluorescence imaging at microdosing using a hybrid PSMA tracer during robot-assisted radical prostatectomy in a large animal model
    Paolo Dell’Oglio, Danny M. van Willigen, Matthias N. van Oosterom, Kevin Bauwens, Fabian Hensbergen, Mick M. Welling, Huijbert van der Stadt, Elise Bekers, Martin Pool, Pim van Leeuwen, Tobias Maurer, Fijs W. B. van Leeuwen, Tessa Buckle
    EJNMMI Research 2022 12 1
  • Highlight selection of radiochemistry and radiopharmacy developments by editorial board
    Emerson Bernardes, Peter Caravan, R. Michael van Dam, Winnie Deuther-Conrad, Beverley Ellis, Shozo Furumoto, Benjamin Guillet, Ya-Yao Huang, Hongmei Jia, Peter Laverman, Zijing Li, Zhaofei Liu, Filippo Lodi, Yubin Miao, Lars Perk, Ralf Schirrmacher, Johnny Vercoullie, Hua Yang, Min Yang, Xing Yang, Junbo Zhang, Ming-Rong Zhang, Hua Zhu
    EJNMMI Radiopharmacy and Chemistry 2022 7 1
  • Synthesis and preclinical evaluation of novel 99mTc-labeled PSMA ligands for radioguided surgery of prostate cancer
    Jan-Philip Kunert, Max Müller, Thomas Günther, León Stopper, Nicole Urtz-Urban, Roswitha Beck, Hans-Jürgen Wester
    EJNMMI Research 2023 13 1
  • The role of [99mTc]Tc-HFAPi SPECT/CT in patients with malignancies of digestive system: first clinical experience
    Xi Jia, Xinru Li, Bing Jia, Ye Yang, Yuanbo Wang, Yan Liu, Ting Ji, Xin Xie, Yu Yao, Guanglin Qiu, Huixing Deng, Zhaohui Zhu, Si Chen, Aimin Yang, Rui Gao
    European Journal of Nuclear Medicine and Molecular Imaging 2023 50 4
  • 99mTc-Labelled Low Molecular Weight Inhibitors of Prostate-Specific Membrane Antigen
    Viktoriia K. Tishchenko, Vasily M. Petriev, Oksana P. Vlasova, Andrei A. Pankratov, Natalia B. Morozova, Petr V. Shegai, Sergei A. Ivanov, Andrei D. Kaprin
    Annals of the Russian academy of medical sciences 2023 77 6
  • 99mTc-PSMA Left Behind: a Call for Collaboration
    Soroush Zarehparvar Moghadam, Emran Askari, Kamran Aryana
    Nuclear Medicine and Molecular Imaging 2022 56 4
  • Delayed Imaging Improves Lesion Detectability in [99mTc]Tc-PSMA-I&S SPECT/CT in Recurrent Prostate Cancer
    Christoph Berliner, Lisa Steinhelfer, Maythinee Chantadisai, Markus Kroenke, Daniel Koehler, Randi Pose, Peter Bannas, Sophie Knipper, Matthias Eiber, Tobias Maurer
    Journal of Nuclear Medicine 2023

Article usage

Article usage: December 2020 to May 2023

AbstractFullPdf
Dec 2020663051
Jan 2021314014
Feb 2021234022
Mar 2021180012
Apr 2021178010
May 2021130018
Jun 2021112025
Jul 20212421247
Aug 20218396053
Sep 20214611534
Oct 20214392050
Nov 20213342052
Dec 20213681021
Jan 20224542675
Feb 20224734242
Mar 20224829852
Apr 20224023385
May 20224021753
Jun 20223734549
Jul 20223137439
Aug 20221924433
Sep 20223731048
Oct 20222920848
Nov 20223010941
Dec 20221641040
Jan 20231940926
Feb 20231839040
Mar 20232840938
Apr 20232027048
May 20232718435
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 64 (6)
Journal of Nuclear Medicine
Vol. 64, Issue 6
June 1, 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Radiation dosimetry of Tc99m-PSMA I&S: a single-center prospective study
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Radiation dosimetry of Tc99m-PSMA I&S: a single-center prospective study
Szabolcs Urbán, Catherine Meyer, Magnus Dahlbom, István Farkas, Gábor Sipka, Zsuzsanna Besenyi, Johannes Czernin, Jeremie Calais, László Pávics
Journal of Nuclear Medicine Dec 2020, jnumed.120.253476; DOI: 10.2967/jnumed.120.253476

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Radiation dosimetry of Tc99m-PSMA I&S: a single-center prospective study
Szabolcs Urbán, Catherine Meyer, Magnus Dahlbom, István Farkas, Gábor Sipka, Zsuzsanna Besenyi, Johannes Czernin, Jeremie Calais, László Pávics
Journal of Nuclear Medicine Dec 2020, jnumed.120.253476; DOI: 10.2967/jnumed.120.253476
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Clinical Investigations (Human)

  • PSMA PET Tumor–to–Salivary Gland Ratio to Predict Response to [177Lu]PSMA Radioligand Therapy: An International Multicenter Retrospective Study
  • PSMA-GCK01 - A Generator-Based 99mTc-/188Re-Theranostic Ligand for the Prostate-Specific Membrane Antigen
  • The added value of 18F-FDG PET/CT compared to 68Ga-PSMA PET/CT in patients with castration-resistant prostate cancer
Show more Clinical Investigations (Human)

Clinical (Oncology: GU)

  • PSMA PET Tumor–to–Salivary Gland Ratio to Predict Response to [177Lu]PSMA Radioligand Therapy: An International Multicenter Retrospective Study
  • PSMA-GCK01 - A Generator-Based 99mTc-/188Re-Theranostic Ligand for the Prostate-Specific Membrane Antigen
  • Pretherapeutic Comparative Dosimetry of 177Lu-rhPSMA-7.3 and 177Lu-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer
Show more Clinical (Oncology: GU)

Similar Articles

Keywords

  • Radiobiology/Dosimetry
  • Radiotracer Tissue Kinetics
  • SPECT/CT
  • PSMA I&S
  • prostate cancer
  • Tc99m-Mas3-y-nal-k(Sub-KuE)
  • dosimetry
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire